锲而不舍、力克肝疾——贾继东教授

doi:10.3969/j.issn.1006-7795.2020.05.022

首都医科大学学报 ›› 2020, Vol. 41 ›› Issue (5): 839-843.doi: 10.3969/j.issn.1006-7795.2020.05.022

锲而不舍、力克肝疾——贾继东教授

单姗, 丛敏

首都医科大学附属北京友谊医院肝病中心, 北京 100050

收稿日期:2020-09-14 出版日期:2020-10-21 发布日期:2020-10-26

Devoted to the prevention and control of liver diseases——Professor Jia Jidong

Shan Shan, Cong Min

Liver Research Centre, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

Received:2020-09-14 Online:2020-10-21 Published:2020-10-26

摘要/Abstract

摘要： 贾继东，医学博士，主任医师、教授、博士生导师，现任首都医科大学附属北京友谊医院肝病中心主任、国家消化系统疾病临床研究中心副主任，并兼任多个国内外肝病学术团体及杂志的重要职务。其主要科研方向为慢性肝病肝纤维化发生机制，以及自身免疫性、胆汁淤积性及遗传代谢性肝病的临床诊疗。

关键词: 肝病, 发病机制, 诊疗

Abstract: Dr. Jia Jidong, MD, PhD, is a professor of medicine, director of Liver Research Centre, Beijing Friendship Hospital, Capital Medical University, and vice director of National Clinical Research Center for Digestive Diseases in Beijing, China. Dr. Jia has served as the president of national, regional and world organizations of liver diseases. He has also served as the associated editor of several renown peer review national and international journals in the field of liver diseases. His main research interests include the pathogenesis and therapeutics of liver fibrosis, the diagnosis and treatment of autoimmune, cholestatic and genetic liver diseases.

Key words: liver disease, pathogenesis, the diagnosis and treatment

中图分类号:

单姗, 丛敏. 锲而不舍、力克肝疾——贾继东教授[J]. 首都医科大学学报, 2020, 41(5): 839-843.

Shan Shan, Cong Min. Devoted to the prevention and control of liver diseases——Professor Jia Jidong[J]. Journal of Capital Medical University, 2020, 41(5): 839-843.

参考文献

[1] Wu X, Wang Y, Cui Y, et al. Hepatitis B virus directly promotes collagen I expression of LX-2 cells without infection in vitro[J]. Hepatol Res, 2012,42(9):911-921.
[2] Li H, Zheng H W, Chen H, et al. Hepatitis B virus particles preferably induce Kupffer cells to produce TGF-β1 over pro-inflammatory cytokines[J]. Dig Liver Dis,2012,44(4):328-333.
[3] Fan W, Liu T, Chen W, et al. ECM1 prevents activation of transforming growth factor β, hepatic stellate cells, and fibrogenesis in mice[J]. Gastroenterology,2019,157(5):1352-1367.
[4] Sun Y, Zhou J, Wang L, et al. New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment[J]. Hepatology,2017,65(5):1438-1450.
[5] Kleiner D E. On beyond staging and grading:Liver biopsy evaluation in a posttreatment world[J]. Hepatology, 2017,65(5):1432-1434.
[6] Wang B, Sun Y, Zhou J, et al. Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients[J]. Mod Pathol, 2018,31(10):1567-1577.
[7] Chen S, Duan W, Li M, et al. Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis:A single center follow-up study from China[J]. J Gastroenterol Hepatol, 2019,34(7):1236-1241.
[8] Li S X, Lv T T, Zhang C P, et al. Alteration of liver-infiltrated and peripheral blood double-negative T-cells in primary biliary cholangitis[J]. Liver Int,2019,39(9):1755-1767.
[9] Lv T, Zhang W, Xu A, et al. Non-HFE mutations in haemochromatosis in China:combination of heterozygous mutations involving HJV signal peptide variants[J]. J Med Genet, 2018,55(10):650-660.
[10] Zhang W, Xu A, Li Y, et al. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin:A recurrent cause of haemochromatosis in China[J]. Liver Int, 2019,39(6):1120-1127.
[11] Li X, Zhang W, Zhou D, et al. Complex ATP7B mutation patterns in Wilson disease and evaluation of a yeast model for functional analysis of variants[J]. Hum Mutat,2019,40(5):552-565.

[1]	张莹, 刘超楠, 时红林, 刘芳, 陈德喜, 时红波. P53凋亡刺激蛋白2介导酒精性肝病脂代谢相关基因的转录组学分析[J]. 首都医科大学学报, 2023, 44(1): 85-92.
[2]	高曼, 李海燕. 中医药信息学应用研究热点[J]. 首都医科大学学报, 2022, 43(4): 592-599.
[3]	李巍, 郝婵娟. 儿童遗传病病因的探寻者——李巍教授团队[J]. 首都医科大学学报, 2020, 41(5): 730-735.
[4]	胡琪, 钟正, 刘激扬, 汤渝玲, 周志国, 刘萍, 阎昱升, 李波. 57例新型冠状病毒肺炎治愈患者胸部电子计算机断层扫描特征报告[J]. 首都医科大学学报, 2020, 41(4): 627-630.
[5]	金荣华. 新型冠状病毒肺炎[J]. 首都医科大学学报, 2020, 41(2): 149-154.
[6]	柯静, 曹斌, 蒋志锋, 丁琳, 刘佐军, 张喜维, 李晓辉, 纪智礼. 多学科协作诊疗模式在新型冠状病毒肺炎患者诊疗中的价值[J]. 首都医科大学学报, 2020, 41(2): 298-301.
[7]	毕研贞, 陈煜. 终末期肝病患者肠屏障功能的变化及营养干预研究进展[J]. 首都医科大学学报, 2018, 39(5): 759-764.
[8]	王虎生, 阮祥燕, 李扬璐, 程姣姣, 谷牧青, 杜娟, 金凤羽, Alfred O. Mueck. 丙二醛、视黄醇与多囊卵巢综合征发病机制关系的探索[J]. 首都医科大学学报, 2018, 39(4): 512-516.
[9]	张闻平, 吴静, 任美杰, 陈燕星, 李科纯, 杨佩仪, 杨坚伟, 王梦楠, 聂美玲. 非酒精性脂肪肝病与血清铁及铁蛋白的相关性研究[J]. 首都医科大学学报, 2015, 36(5): 778-781.
[10]	张声生, 李晓玲. 功能性消化不良的中西医研究进展[J]. 首都医科大学学报, 2015, 36(4): 649-653.
[11]	杨迪亚, 王宁利. 原发性开角型青光眼新防治技术的建立及应用2014年度国家科学技术进步二等奖[J]. 首都医科大学学报, 2015, 36(1): 1-7.
[12]	王怀洲, 王宁利. 原发性闭角型青光眼发病机制与防治体系的建立及应用——2013年度国家科学技术进步二等奖[J]. 首都医科大学学报, 2014, 35(1): 6-9.
[13]	张婷;许强;杨紫伟;蒋素贞;鲁凤民;陈香梅;庄辉. 原发性肝细胞癌中乙型肝炎病毒基因整合的突变分析[J]. 首都医科大学学报, 2011, 32(3): 313-317.
[14]	常路丝;乔雍;魏洪莲;肖凡;郝晓花;张仁雯;成军;魏红山. HBV相关分泌蛋白c18orf54的克隆表达及初步功能研究[J]. 首都医科大学学报, 2011, 32(3): 318-323.
[15]	胡智阗;车念聪;夏蓉;袁梦. 胰岛素抵抗与非酒精性脂肪性肝病关系的实验研究[J]. 首都医科大学学报, 2009, 30(2): 218-221.

锲而不舍、力克肝疾——贾继东教授

Devoted to the prevention and control of liver diseases——Professor Jia Jidong

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价